PharmTech Drug Digest 11.20
News|Articles|September 24, 2021

ProductLife Group and Juuka Advisory Partner Up on New Consulting Venture

ProductLife Group (PLG) and Juuka Advisory have teamed up to form a new consulting offering, ProductLife Consulting.

ProductLife Group (PLG), a regulatory compliance and outsourcing services specialist, and Juuka Advisory, an operations consulting company, have teamed up to form a new consulting offering, ProductLife Consulting. The partnership was announced in a Sep. 20, 2021 press release.

Both PLG and Juuka will draw from their expertise and operational experience to provide an end-to-end services portfolio for the pharma, biotech, medtech, and cosmetics markets through the new venture. ProductLife Consulting will be headed by Jean-Luc Taborin, who is Jukka’s CEO.

“I’m proud to join PLG, a leader in regulatory compliance outsourcing services,” said Taborin, in the press release. “With their knowledge of drug development, we’ll be able to tackle any perspective of the development of pharma, biotech, medtech, or cosmetics companies end-to-end.”

“This is a key milestone in PLG’s roadmap to strengthen its consulting offering with senior principals such as Jean-Luc and his team,” added Xavier Duburcq, CEO of ProductLife Group, in the press release. “PLG’s service offering and global footprint can now be proposed as a follow-up to any strategic recommendation that ProductLife Consulting makes to groups that want to accelerate and perform in their markets.”

Source: PLG


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.